(Q54256356)

26 May 2018

title

The significance of oxalate in renal failure. (English)

1 reference

26 May 2018

author name string

C S Thompson

series ordinal

1

1 reference

26 May 2018

E J Weinman

series ordinal

2

1 reference

26 May 2018

publication date

1 September 1984

1 reference

26 May 2018

American Journal of Kidney Diseases

published in

1 reference

26 May 2018

volume

4

1 reference

26 May 2018

issue

2

1 reference

26 May 2018

page(s)

97-100

1 reference

26 May 2018

Plasma oxalate concentration in chronic renal disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980055-4

7 January 2021

Oxalate removal by hemodialysis in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980055-4

7 January 2021

Mechanism for Hyperoxaluria in Patients with Ileal Dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980055-4

7 January 2021

Urinary oxalate excretion after large intakes of ascorbic acid in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980055-4

7 January 2021

Plasma Level and Renal Clearance of Oxalate in Normal Subjects and in Patients with Primary Hyperoxaluria or Chronic Renal Failure or Both

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980055-4

7 January 2021

Renal tubular transport of organic acids. Studies with oxalate and para-aminohippurate in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980055-4

7 January 2021

Histopathological occurrence and characterisation of calcium oxalate: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980055-4

7 January 2021

PRIMARY HYPEROXALURIA

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980055-4

7 January 2021

Renal damage with intestinal bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980055-4

7 January 2021

Elevation of the Concentration of Plasma Oxalic Acid in Renal Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980055-4

7 January 2021

Oxalosis as a complication of chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980055-4

7 January 2021

Calcium oxalate microcrystalline-associated arthritis in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980055-4

7 January 2021

Calcium oxalate kidney stones in patients on continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980055-4

7 January 2021

Dialysis in the treatment of primary hyperoxaluria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980055-4

7 January 2021

Effect of vitamin B6 administration on elevated plasma oxalic acid levels in haemodialysed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980055-4

7 January 2021

Secondary oxalosis as a complication of parenteral alimentation in acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980055-4

7 January 2021

Successful strategies for renal transplantation in primary oxalosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980055-4

7 January 2021

10.1016/S0272-6386(84)80055-4

Identifiers

DOI

1 reference

26 May 2018

1 reference

26 May 2018